{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:03:14Z","timestamp":1788386594944,"version":"build-2803163510"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"DOI":"10.1093\/jjco\/hyw011","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T01:49:58Z","timestamp":1457401798000},"page":"415-420","source":"Crossref","is-referenced-by-count":7,"title":["Effect of olanzapine for breast cancer patients resistant to triplet antiemetic therapy with nausea due to anthracycline-containing adjuvant chemotherapy"],"prefix":"10.1093","volume":"46","author":[{"given":"Junya","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Iwate Medical University Hospital, Morioka"},{"name":"Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Iwate Medical University, Morioka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kashiwaba","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, Iwate Medical University, Morioka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, Iwate Medical University, Morioka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, Iwate Medical University, Morioka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nihei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Iwate Medical University Hospital, Morioka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Iwate Medical University Hospital, Morioka"},{"name":"Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Iwate Medical University, Morioka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"key":"key\n\t\t\t\t2018110606054053100_HYW011C1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","article-title":"On the receiving end-patient perception of the side-effects of cancer chemotherapy","volume":"19","author":"Coates","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/bjc.1997.507","article-title":"Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists","volume":"76","author":"de Boer-Dennert","year":"1997","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C3","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1200\/JCO.2003.01.095","article-title":"The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group","volume":"21","author":"Hesketh","year":"2003","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6004\/jnccn.2007.0004","article-title":"Antiemesis","volume":"5","author":"Ettinger","year":"2007","journal-title":"J Natl Compr Canc Netw"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.suponc.2011.05.002","article-title":"Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial","volume":"9","author":"Navari","year":"2011","journal-title":"J Support Oncol"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C8","article-title":"NCCN Clinical Practice Guidelines in Oncology-Antiemesis-ver. 2","year":"2013"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C9","article-title":"JSCO Clinical practice guidelines 2015 for antiemesis","author":"Japanese Society of Clinical Oncology","year":"2015"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C10","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J Clin Oncol"},{"issue":"(Suppl 5)","key":"key\n\t\t\t\t2018110606054053100_HYW011C11","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","article-title":"Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference","volume":"21","author":"Roila","year":"2010","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C12","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.9621","article-title":"Palonosetron (PALO) versus granisetron (GRA) in the triplet regimen with dexamethasone (DEX) and aprepitant (APR) for preventing chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving highly emetogenic chemotherapy (HEC) with cisplatin (CDDP): a randomized, double-blind, phase III trial","author":"Hashimoto","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0893-133X(95)00069-P","article-title":"Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial","volume":"14","author":"Beasley","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2018110606054053100_HYW011C15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","article-title":"Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan","volume":"20","author":"Tamura","year":"2015","journal-title":"Int J Clin Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/46\/5\/415\/26367946\/hyw011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T20:27:59Z","timestamp":1600288079000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/46\/5\/415\/2218889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,19]]},"published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyw011","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,5]]},"published":{"date-parts":[[2016,5,1]]}}}